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Abstract
Akt represents a nodal point between the Insulin receptor and TOR signaling, and its activation by phosphorylation controls
cell proliferation, cell size, and metabolism. The activity of Akt must be carefully balanced, as increased Akt signaling is
frequently associated with cancer and as insufficient Akt signaling is linked to metabolic disease and diabetes mellitus.
Using a genome-wide RNAi screen in Drosophila cells in culture, and in vivo analyses in the third instar wing imaginal disc,
we studied the regulatory circuitries that define dAkt activation. We provide evidence that negative feedback regulation of
dAkt occurs during normal Drosophila development in vivo. Whereas in cell culture dAkt is regulated by S6 Kinase (S6K)–
dependent negative feedback, this feedback inhibition only plays a minor role in vivo. In contrast, dAkt activation under
wild-type conditions is defined by feedback inhibition that depends on TOR Complex 1 (TORC1), but is S6K–independent.
This feedback inhibition is switched from TORC1 to S6K only in the context of enhanced TORC1 activity, as triggered by
mutations in tsc2. These results illustrate how the Akt–TOR pathway dynamically adapts the routing of negative feedback in
response to the activity load of its signaling circuit in vivo.
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Introduction
The development of multi-cellular organisms depends on the
precise choreography of a diverse array of signal transduction
pathways. Besides the requirement of some signaling events to
occur in a spatial or temporal on-off manner, other pathways need
to stay homeostatically active within physiological boundaries.
This requires balanced regulation by activating as well as
repressing signals.
Mechanistically, three basic concepts of downregulating signal-
ing pathway have emerged: (1) control via specific inhibitory
ligands or receptors [1,2], (2) negative cross-regulation by distinct
signaling pathways [3], and (3) auto-regulation by negative
feedback mechanisms [4,5]. In most cases, the molecular
component that executes the feedback-mediated inhibition is
transcriptionally targeted by the very pathway that it regulates.
This mechanism ensures an interdependence of signaling activity
and feedback regulation and is often viewed as an inherent means
to downregulate signaling pathways after stimulation.
Loss of negative feedback regulation has been correlated with
the initiation, growth and progression of tumors. For example, loss
of negative feedback in Hedgehog (Hh) signaling by impeding
patched function results in ectopic Hh signaling, basal cell
carcinoma and medulloblastomas [6]. The expression of axin2 or
dickkopf-1, which encode feedback inhibitors of Wnt signaling, is
silenced in colon and breast carcinomas and early lung
adenocarcinoma [7,8]. Negative feedback regulators of Ras
signaling, such as Sprouty proteins and MAPK phosphatases,
are downregulated in liver, prostate and breast cancers
[9,10,11,12]. Similarly, inhibition of negative feedback regulation
has been reported for JAK/STAT, TGF-beta and NF-kappaB
signaling pathways [13,14,15]. These observations indicate that
some cancers arise by ‘‘breaching’’ auto-regulatory control
mechanisms of signaling pathways via mutational inactivation or
epigenetic silencing of negative feedback regulators.
The Akt-TOR pathway has emerged as a central signaling
nexus that integrates responses to growth factors, nutrients,
metabolites and stress. Most prominently, activation of Akt is
initiated by the insulin receptor (InR), relayed via an intracellular
signaling cascade comprising insulin receptor substrate (IRS), class
IA PI3 Kinase (PI3K), PDK1 and TOR complex 2 (TORC2),
consisting of TOR, Rictor, Sin1, Lst8 and PRR5L
[16,17,18,19,20]. Among other substrates, Akt inhibits the
activities of the transcription factor FoxO [21] and the Rheb-
specific GTPase activating protein (GAP) Tsc2. In turn, Rheb
regulates the TOR complex 1 (TORC1), containing TOR, Raptor
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and Lst8 [17,22,23]. TORC1 targets several well characterized
substrates, most notably S6 Kinase (S6K) [24,25]. Hence, the two
distinct TOR complexes TORC1 and TORC2 both participate in
Akt-TOR signaling, but act at different levels in the Akt-TOR
signaling pathway and integrate distinct stimuli. TORC2 responds
to growth factors and might determine the substrate specificity of
Akt [26,27,28,29], while TORC1 mediates signaling by amino
acids and cellular energy stress [30,31,32,33]. Ectopic activation of
the core Akt-TOR signaling pathway by a variety of mechanisms
is a frequent event in cancer biology [18,34]. Moreover, chronic
diseases such as obesity and type II diabetes show pathological
alteration of Akt-TOR activity [35].
Negative feedback mechanisms regulate the signaling input into
the Akt-TOR pathway. Indeed, FoxO transcription factors inhibit
the activity of the phosphatases PP2A and calcineurin by driving
the expression of Atrogin-1, causing elevated levels of Akt
phosphorylation and activity [36,37]. Furthermore, Akt-depen-
dent inhibition of the FoxO transcription factor results in reduced
transcription of the inR gene. Conversely, low Akt-TOR signaling
selectively increases InR mRNA translation relative to the total
mRNA pool. In conjunction, both mechanisms reduce the relative
levels of InR expression when Akt-TOR activity is high, thereby
desensitizing against a stimulating ligand [38,39,40]. In addition,
an S6K-dependent negative feedback mechanism leads to IRS1
destabilization, thus decreasing Akt activity [41,42,43,44]. While
these negative feedback mechanisms have been defined in cell
culture, it is currently unknown whether and how feedback
regulation within the Akt-TOR signaling pathway is exerted
during development in vivo.
In Drosophila, the dAkt-TOR signaling pathway is conserved and
regulates cell proliferation, and developmental timing and sizing of
cells, organs and the whole fly [45,46,47]. As with the mammalian
counterparts, Drosophila Akt receives regulatory inputs from
TORC2 as well as PDK1. The phosphorylation site in the C-
terminal hydrophobic motif of Drosophila Akt is conserved, and,
while dispensable for normal Drosophila development, is required
for relaying high PI3K signaling levels [29,48,49,50]. Similarly,
prostate-specific ablation of C-terminal Akt phosphorylation in
mice conditionally mutant for Rictor delays lethality of Pten+/-
induced prostate cancer [51]. In general, the C-terminal
phosphorylation of Akt has emerged as a valuable and reliable
tool to detect Akt activity in vivo and in vitro [52,53]. In contrast to
the three Akt genes in mammalian genomes, Drosophila contains
only a single dAkt gene. In addition, the InR and IRS families are
represented solely as single genes, and the insulin/InR-related
IGF-1/IGFR system is absent in flies. This simplicity underscores
the suitability of the fly as a model organism for studying complex
processes like the in vivo analysis of feedback mechanisms.
To date, the analysis of feedback-mediated Akt-TOR pathway
adaptation has been pursued under genetic or metabolic
conditions that trigger high, possibly supra-physiological activity
of TORC1 and S6K, and mostly in cell culture systems [18,54]. In
this study, we present evidence that regulation by negative
feedback is an integral part of the dAkt-TOR pathway in vivo.
Importantly, we demonstrate that the pathway utilizes two distinct
modes of negative feedback to downregulate its activity in vivo,
independently of FoxO. Conditions of wild-type TORC1 activity
favor a dampening feedback signal emanating from TORC1 itself,
independent of S6K. In contrast, conditions that induce high
TORC1 activity trigger an S6K-dependent feedback mechanism
to dampen dAkt-TOR pathway signaling. Our observations
suggest that S6K acts as a load-sensitive regulator of Akt-TOR
signaling. We propose the presence of a novel dual ‘‘overload
protection’’ circuit that emphasizes the importance of tight control
over Akt-TOR pathway signal levels.
Results
An assay for Drosophila phospho-Akt
We established a cell-based assay for regulators of insulin
signaling in Drosophila that could be used in a genome-wide RNAi
screen. Testing of more than 64 commercially available phospho-
antibodies against components of this signaling cascade revealed
that none of them recognized an insulin-induced antigen using
immunohistochemistry (data not shown). Thus, we generated a
phospho-Akt antiserum recognizing the phosphorylation of the C-
terminal hydrophobic motif of Drosophila Akt. The single dakt gene
encodes two splice forms of 513 and 611 amino acids in length.
The antibody (hereafter referred to as anti P-dAkt) recognizes two
bands in a western blot assay, likely corresponding to the
phosphorylated forms of the short and long splice form,
respectively.
In order to test if the phosphorylation of this hydrophobic motif
correlates well with activity of Akt [52,53], we stimulated Drosophila
Kc167 cells with insulin for 10 min and induced a robust P-dAkt
signal. The hydrophobic motif phosphorylation was strongly
suppressed when known components of the insulin signaling
cascade, including InR, Chico, the catalytic subunit of PI3K,
PI3K92E and dAkt itself were silenced by RNAi (Figure 1A–1E
and 1A’–1E’). We next asked whether the anti P-dAkt antibody
detected differences in dAkt phosphorylation in the third instar
imaginal disc, an established system to study cell and tissue size
alterations dependent InR signaling in vivo [55,56,57]. To validate
our assay, we expressed dominant negative insulin receptor
(InRDN) or a constitutively active catalytic subunit of PI3K
(PI3KCAAX), utilizing the UAS-Gal4 expression system [58]. Using
apterous-Gal4 (ap-Gal4) to drive expression of InRDN and
PI3KCAAX concomitant with membrane-tagged GFP in the dorsal
compartment of the wing disc, we compared the levels of P-dAkt
Author Summary
The development of multi-cellular organisms depends on
the precise choreography of a diverse array of signal
transduction pathways. This requires balanced regulation
by activating as well as repressing signals. Negative
feedback, defined as a signaling response counteracting
the stimulus, is a frequently used mechanism to dampen
signaling pathway activity. Accordingly, loss of negative
feedback is often observed during progression of cancer,
while constitutive engagement of negative feedback
contributes to chronic loss-of-function phenotypes. Ectop-
ic activation of the Akt–TOR pathway is frequently
associated with tumor susceptibility and cancer and
contributes to obesity-induced metabolic disease and type
II diabetes. Using Drosophila cell culture and the develop-
ing fly, we dissect the regulatory circuitry defining
negative feedback regulation of dAkt. Our work shows
that dAkt activity is regulated by two qualitatively different
negative feedback mechanisms and that the activity level
of the dAkt pathway dictates which feedback mechanism
is utilized. Under normal physiological activity conditions,
we observe a feedback mechanism that is dependent on
TOR complex 1, but independent of S6K. Under conditions
of pathological high pathway activity, we observe an S6K–
dependent negative feedback mechanism. Our identifica-
tion of a quantitative-to-qualitative switch in dAkt–TOR
negative feedback signaling might have important impli-
cations in the biology of cancer and metabolic diseases.
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Figure 1. Specificity of anti P-dAkt. (A-J’) Drosophila Kc167 cells stained with DAPI (blue), anti P-dAkt (red), and anti alpha-tubulin (green) after 10
minutes of insulin stimulation (A-E’) or at baseline without insulin stimulus (F-J’). Cells were RNAi treated as described in the experimental procedures
using no dsRNA (A, A’), InR dsRNA (B, B’, G, G’), Chico dsRNA (the IRS ortholog, C, C’, H, H’), PI3K93E dsRNA (the catalytic subunit of the class IA PI3-
Kinase, D, D’, I, I’) and dAkt (E, E’, J, J’). Note that large polynucleated cells are resistant to the insulin stimulus (A, A’). (K-L’) Single tangential optical
sections of third instar wing imaginal discs. The region of the dorso-ventral (D/V) boundary at the future wing pouch is shown, dorsal to the left. Wing
discs are stained with DAPI (blue), anti P-dAkt (red) and anti-GFP (green), marking the expression domain of apterous-Gal4 and the UAS-InRDN (K, K’)
and UAS-PI3KCAAX (L, L’) expression constructs. K’ and L’ show P-dAkt channels only, the D/V compartment boundary is marked by a white line.
doi:10.1371/journal.pgen.1000990.g001
Negative Feedback Regulation of Drosophila Akt
PLoS Genetics | www.plosgenetics.org 3 June 2010 | Volume 6 | Issue 6 | e1000990
immunoreactivity in the dorsal compartment cells to non-
expressing ventral cells as controls (Figure 1K–1L and 1K’–1L’).
Expression of InRDN resulted in a reduction of P-dAkt levels
(Figure 1F and 1F’), whereas PI3KCAAX expression drastically
increased the P-dAkt intensity when compared to ventral control
cells (Figure 1G and 1G’). Staining of wild-type imaginal wing
discs did not reveal a pattern of P-dAkt immunoreactivity
associated with compartments or their boundaries (not shown).
Western blotting of extracts of Kc167 cells treated with various
dsRNAs against components of the insulin signaling pathway
confirmed the specificity found by immunostaining of cells and
Drosophila tissue (Figure S1). RNAi-mediated knockdown of InR,
PI3K92E or dAkt abolished the anti-P-dAkt reactivity. Together,
our data show that anti P-dAkt faithfully detects dAkt phosphor-
ylation, and that the hydrophobic phosphorylation motif correlates
with InR-PI3K regulated dAkt activity in cell culture and in vivo.
A genome-wide RNAi screen for regulators of P-dAkt
reveals negative feedback regulation by Tsc1/Tsc2-TOR-
S6K signaling
To identify novel regulatory inputs in the insulin signal
transduction pathway, we used the Cytoblotting/In Cell Western
method in combination with the newly generated anti P-dAkt
antibody (Figure S2A) as a fast and quantitative cell-based high
throughput assay. Cells were grown in 384-well plates and, after
three days in the presence of gene-specific dsRNAs of the genome-
wide dsRNA library [59], were fixed and immunostained with anti
P-dAkt antiserum. Bound primary antibody was quantified and
normalized to cell number. Using this approach, we carried out
genome-wide RNAi screens in duplicates without stimulation and
after 10 min. of insulin stimulation. We identified 79 dsRNAs that
conferred suppression of dAkt phosphorylation, and 56 dsRNAs
that enhanced P-dAkt immunoreactivity (Table S1). Importantly,
five out of eight known components functioning upstream of dAkt
were identified, validating the reliability of this method (Figure
S2B, S2C, and Table S1). dsRNAs against Chico, PHLLP and Pten,
the remaining 3 regulators of dAkt, scored below the cutoff
threshold.
In our screens, we found that dsRNAs against the small GTPase
Rheb, the TORC1 component Raptor and S6K, all downstream
mediators required for insulin signal transduction, induced
enhanced phosphorylation of dAkt in the absence of insulin.
Conversely, dsRNAs against the negative regulators Tsc1 and Tsc2
suppressed the P-dAkt signal when the pathway was activated by
insulin. In total, we identified ten out of eleven components known
to participate in the Tsc1/Tsc1-TOR signaling branch, with Tctp
[60] as the single component not identified by any of our screens
(Figure S2 and Table S1). Interestingly, the function of Tctp as a
regulator of Rheb is controversial [61,62]. The results of the
genome-wide RNAi screen were validated using independent
dsRNAs against known insulin pathway components (Figure 2A
and 2B). dsRNAs against CSK, MEKK1 and Thread were used as
negative controls, and Pten dsRNA as positive control. As observed
in the genome-wide screen, removal of the negative regulators
Tsc1 and Tsc2 resulted in suppression of P-dAkt in the presence of
insulin, while knock down of S6K elevated P-dAkt at baseline
conditions. Thus, dAkt phosphorylation is sensitive to interference
by Tsc1/Tsc2-TOR-S6K signaling, classically viewed as signaling
downstream of dAkt [23,63,64,65,66,67]. These results are
consistent with the existence of an inhibitory feedback signal by
the components downstream of dAkt, namely Rheb, Raptor,
Tsc1/2 and S6K [50,65].
To test the feedback by different means than RNAi, two
different strategies were used to inhibit the activator of S6K,
TORC1 (Figure 2C). In a chemical approach, we exposed
cultured cells to rapamycin, an effective, small molecule inhibitor
of TORC1 [68,69,70]. In a metabolic approach, we starved
cultured cells in amino acid-free media, thereby potently inhibiting
TORC1 activity [65,68,69,70,71]. Rapamycin-induced TORC1
inhibition and amino acid starvation both led to a highly
significant increase in P-dAkt compared to control cells treated
with solvent control or amino acid-containing medium, respec-
tively. These results confirm the RNAi data and validate the
existence of a negative feedback loop that regulates the activation
of the pathway by insulin [65].
Activation of S6K correlates with an inhibition of P-dAkt
Since dsRNA-mediated knockdown of S6K enhanced dAkt
phosphorylation, we asked whether the inhibitory effect of S6K on
dAkt phosphorylation was related to its activity. The activation of
Drosophila S6K can be scored using phosphorylation of Thr 398
(orthologous to Thr 389 in mammalian S6K1) as readout
(Figure 3A) [50,65]. We analyzed lysates of Drosophila Kc167 cells
pretreated with dsRNAs against Tsc2, Raptor, S6K and Rheb, for
both S6K and dAkt phosphorylation. Cells treated with dsRNA
against luciferase and non-RNAi treated cells served as negative
controls (Figure 3A, lanes 4 and 6). Enhanced P-dAkt reactivity
correlated with suppression of S6K phosphorylation, with a clear
elevation of dAkt phosphorylation when Rheb, Raptor or S6K
expression was knocked down.
To address how S6K mediates its feedback inhibition of dAkt
phosphorylation, we induced dAkt phosphorylation by exclusively
removing the negative feedback inhibition in Kc167 cells using
RNAi against S6K in the absence of insulin stimulation. The
robust enhancement of P-dAkt due to the knockdown of S6K
expression was not affected by further RNAi-mediated knockdown
of control genes such as GFP, CSK or MEKK1/4. We then knocked
down the individual components of the insulin signaling pathway
to assess whether they were required for the enhanced dAkt
phosphorylation caused by S6K silencing (Figure 3B). In the
S6KRNAi background, RNAi-mediated silencing of Pten (positive
control) further enhanced the P-dAkt levels, while dsRNA to dAkt
(negative control) reduced P-dAkt to baseline levels. Importantly,
RNAi against the signaling effectors InR or PI3K suppressed the
enhanced dAkt phosphorylation conferred by S6K RNAi,
indicating that the S6K-dependent feedback inhibition requires
the functions of these two upstream signaling effectors.
Phosphorylation of dAkt in vivo is regulated by negative
feedback
Cell autonomous regulation of dAkt phosphorylation by direct
negative feedback has to date not been shown to occur in vivo. To
test whether the negative feedback on dAkt phosphorylation also
occurs in vivo, i.e. during Drosophila development, we used the wing
imaginal disc of the third instar larva. We took advantage of the
unique features of the aktq allele [72], a loss of function allele that
encodes a kinase-inactive dAkt protein due to mutation of the
DF327G motif in kinase subdomain VII into DI327G. This dAkt
mutant protein is unable to phosphorylate downstream compo-
nents, but is readily expressed and can be phosphorylated by
upstream signaling components [72]. We generated homozygous
mutant aktq clones in the wing imaginal discs using FLP-FRT-
mediated mitotic recombination using the MARCM technique
[73,74]. This confers GFP expression to the cells expressing the
mutant allele only. dAkt protein expression in aktq mutant clones
and in the neighboring cells expressing wild-type dAkt were at
similar levels (Figure S3). We then visualized dAkt phosphorylation
of aktq mutant and wild-type cells by immunofluorescence using
Negative Feedback Regulation of Drosophila Akt
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Figure 2. Phosphorylation of Akt is regulated by the activity of the InR-PI3K as well as the Tsc1/Tsc2-TOR signaling branch. (A, B) P-
dAkt levels (expressed as calculated Z-Scores, defined as the difference from the average, expressed as multiples of the standard deviation) for
independently synthesized dsRNAs against the InR-PI3K and Tsc1/Tsc2-TOR signaling pathway branches under baseline (A) or insulin-stimulated (B)
conditions. (C, D) P-dAkt phosphorylation levels (expressed as calculated Z-Scores) at baseline (C) and after insulin stimulation (D) of Kc167 cells
pretreated with 50 nM Rapamycin (Rapa) for 4 hrs or amino acid (-aa) and serum-free tissue culture medium (8 hrs). Methanol (MeOH) and aa-
containing medium (+aa) were used as control, respectively. Experiments were analyzed using external standard curves as described in experimental
procedures. P-values were calculated using the two-tailed students t-test.
doi:10.1371/journal.pgen.1000990.g002
Negative Feedback Regulation of Drosophila Akt
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the anti P-dAkt antibody. The presence of an inhibitory
mechanism that depends on the activity of the dAkt kinase and
negatively feeds back on dAkt phosphorylation predicts enhanced
P-dAkt levels in aktq mutant cells when compared to cells
expressing wild-type dAkt. Consistently, we observed drastically
enhanced phosphorylation of dAkt in clones homozygous for the
aktq mutation (Figure 4A). The increased dAkt phosphorylation in
aktq mutant cells thus indicates that inactivation of the dAkt kinase
function removes repression on dAkt phosphorylation by negative
feedback. It further demonstrates the cell autonomous presence of
this regulatory loop in imaginal wing discs of third instar larvae.
Regulation of dAkt phosphorylation by the Tsc1/Tsc2
tumor suppressor complex
Having established that feedback inhibition leads to repression
of dAkt phosphorylation in vivo, we asked whether changes in
Tsc1/Tsc2 function would affect the feedback activity on dAkt
phosphorylation (Figure 4). dAkt-mediated phosphorylation of
Tsc2 inhibits the function of the Tsc1/Tsc2 tumor suppressor
complex [63,75]. First, we co-expressed Tsc1 and Tsc2 in the
dorsal compartment of the third instar imaginal wing disc under
the control of ap-Gal4. If the Tsc1/Tsc2 complex defines the
feedback inhibition of dAkt phosphorylation in vivo, overexpression
of Tsc1/Tsc2 is expected to result in increased dAkt phosphor-
ylation. Indeed, compared to ventral control cells, dAkt phos-
phorylation is clearly elevated in dorsal cells (Figure 4B). This
result indicates that forced Tsc1/Tsc2 expression represses the
feedback inhibition. Conversely, we induced homozygous mutant
clones of either tsc1Q87X or tsc2192, resulting in the lack of
functional Tsc1/Tsc2 tumor suppressor complex [76,77,78].
Complementary to the Tsc1/Tsc2 overexpression experiment,
we expected a decrease in dAkt phosphorylation. Indeed, we
found reduced dAkt phosphorylation levels in tsc1Q87X homozy-
gous mutant cells, when compared to wild-type control cells
(Figure 4C).
Next, we addressed whether the dAkt feedback signaling is
routed from dAkt to the Tsc1/Tsc2 complex by evaluating the P-
dAkt immunoreactivity in aktq, tsc1Q87X double mutant clones. If
Tsc1/Tsc2 transduces the feedback signal originating from dAkt,
we expect that the additional elimination of tsc1 function in an aktq
clone reverses the increased dAkt phosphorylation found in a clone
of aktq single mutant cells. Consistent with this prediction, the level
of dAkt phosphorylation in aktq, tsc1Q87X double mutant clones was
not elevated when compared to cells with wild-type expression of
Tsc1/Tsc2 and dAkt. To the contrary, P-dAkt levels were
decreased, more like cells singly deficient in tsc1 function
(Figure 4C). We therefore conclude that the Tsc1/Tsc2 tumor
suppressor complex controls dAkt phosphorylation in vivo by
defining the feedback inhibition.
Negative feedback regulation of dAkt phosphorylation is
independent of FoxO
Transcription factors of the FoxO family have emerged as
central mediators of the PI3K-dAkt signal transduction pathway
[21,79]. In Drosophila cell culture and the adult fly, the InR
transcript is selectively transcribed and translated under conditions
Figure 3. Inhibition of S6K results in derepression of Akt by inhibition of InR. (A) Immunoblots of total lysates prepared from Drosophila
Kc167 cells after 10 min of insulin stimulation treated with dsRNAs against Tsc2, Raptor, S6K, Luciferase and Rheb as indicated. Non-RNAi treated and
luciferase (luc) dsRNA treated cells were used as negative controls. (B) InR and PI3K are required to mediate S6K dependent negative feedback on
dAkt. Calculated Z-scores of P-dAkt derived from a cytoblot/in cell western under non-stimulated (no insulin), S6K RNAi treated condition, using
untreated cells as reference. DsRNAs are utilized as indicated, RNAi against GFP, CSK and MEKK are used as negative controls, RNAi against Pten and
Akt as positive controls. Values and their SDs are calculated from seven replicates. Please note that dAkt phosphorylation is exclusively derived from
removing S6K dependent negative feedback.
doi:10.1371/journal.pgen.1000990.g003
Negative Feedback Regulation of Drosophila Akt
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of low dAkt signaling levels [38,39,40]. Since these data suggests
an alternative route of feedback mediated regulation of dAkt
phosphorylation that is independent of TORC1 and S6K, we
wanted to test the role of dFOXO in the negative feedback
regulation of dAkt phosphorylation in the third instar imaginal
wing disc. To do so, we used an activated form of dFOXO
(dFOXO-TM), in which the dAkt phosphorylation sites have been
replaced by alanines (Figure S4) [80]. These mutations result in
constitutively nuclear localization of dFOXO, and strong
transactivation of target genes both in vitro and in vivo [38,39,81].
Expression of dFOXO-TM by means of ap-Gal4 did not reveal
any discernable differences in dAkt phosphorylation between
dFOXO-TM expressing versus non-expressing cells (Figure S4A).
Furthermore, mitotic clones homozygous for the dfoxo25 loss of
function allele, which is predicted to encode a truncated protein
[81], retain a similar amount of P-dAkt as wild-type control cells
(Figure S4B). Finally, aktq, dfoxo25 double mutant clones show
increased dAkt phosphorylation, similar to homozygous clones of
aktq alone (Figure S4C). These data indicate that dFOXO is not
involved in the negative feedback regulation of dAkt phosphor-
ylation in the developing wing disc.
Tsc1/Tsc2 regulates dAkt phosphorylation via TORC1
To further delineate the feedback inhibition pathway mediated
by the Tsc1/Tsc2 complex, we analyzed the requirement of
TORC1 in the downregulation of dAkt phosphorylation. The
protein kinase TOR has been found in close physical proximity of
Tsc1 and Tsc2, and biochemical and genetic evidence have
established that TOR is a central mediator of Tsc1/Tsc2 signaling
[76,82,83,84,85]. However, TOR is part of TORC1 as well as
TORC2, and the former is required for S6K activation, which, in
cell culture, brings forth negative feedback on dAkt phosphory-
lation, while the latter is required for hydrophobic motif
phosphorylation of dAkt [16]. To interfere specifically with
TORC1 function, we expressed an RNAi hairpin construct
against Raptor (raptorRNAi), a component present only in TORC1
and not in TORC2 [49,86]. Using ap-Gal4, we compared the
dAkt phosphorylation levels in UAS-RaptorRNAi expressing, GFP-
positive dorsal cells to those in wild-type, GFP-negative control
cells in the ventral compartment (Figure 5A). If TORC1 is
required to drive feedback inhibition of dAkt phosphorylation, its
inactivation should augment the level of P-dAkt immunoreactivity.
Accordingly, we observed increased P-dAkt staining in RaptorRNAi
cells.
We further tested whether TORC1 is required for the decrease
in dAkt phosphorylation observed in tsc1 mutant wing disc cells.
We expressed raptorRNAi in mitotic clones homozygously mutant for
tsc1W243X. Loss of tsc1 results in derepression of Rheb and TORC1
activity [23,64], which, accordingly, resulted in excessive feedback
inhibition of dAkt phosphorylation in tsc1 mutant cells (Figure 5B).
Feedback inhibition by Tsc1/Tsc2 mediated through TORC1
predicts that loss of tsc1 concomitant with a reduction of raptor
function by RNAi confers the same P-dAkt phenotype as that of
raptorRNAi alone. Indeed, raptorRNAi expression in tsc1W243X mutant
cells displayed an increase in P-dAkt immunostaining, as seen in
cells expressing raptorRNAi alone (Figure 5C). This is consistent with
Figure 4. The Akt–TOR signal transduction pathway has a circular structure in vivo. Single tangential optical sections (A,A’-D,D’) of third
instar wing imaginal discs stained with DAPI (A-D, blue), anti P-dAkt (A-D’, red) and anti-GFP (A-D, green). (A, A’) MARCM, M+ clone of aktq located at
the wing primordium. (B, B’) View of the dorso-ventral boundary at the future wing pouch. GFP expression (green) marks the dorsal expression
domain of apterous-Gal4 driver used to co-express UAS-Tsc1 and UAS-Tsc2. (C, C’) tsc1Q87X homozygous mutant MARCM clones located at the wing
primordium. (D, D’) MARCM, M+ aktq, tsc1Q87X homozygous mutant clones located at the wing primordium. Mutant clones are marked by the
expression of GFP (green) in A, C and D. A’- D’ show P-dAkt channels only, the compartment boundary (B’) or the boundaries of the clones (A’, C’, D’)
are traced with a white line. Genotypes: (A, A’) hs-FLP, UAS-GFPnuc, tub-Gal4/+; FRT82B, aktq/FTR82B, tub-Gal80, M. (B, B’) yw; ap-Gal4/+, UAS-Tsc1, UAS-
Tsc2/+. (C, C’) hs-Flp, UAS-CD8::GFP; tub-Gal4/+; FRT82B, tsc1Q87X/FRT82B, tub-Gal80. (D, D’) hs-FLP, UAS-GFPnuc, tub-Gal4/+; FRT82B, aktq, tsc1Q87X/
FTR82B, tub-Gal80, M.
doi:10.1371/journal.pgen.1000990.g004
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the loss of negative feedback inhibition of dAkt phosphorylation in
raptorRNAi, tsc1W243X cells, indicating an epistatic relationship of
TORC1 to Tsc1 in the negative feedback circuit.
Two distinct modes of inhibitory feedback signaling to
dAkt
S6K is a central player downstream of TORC1, and TORC1
activity is directly required for the activation of S6K [25,35]. To
test the role of S6K in the feedback inhibition of dAkt
phosphorylation, we generated homozygous clones of an s6K null
allele (s6Kl-1) [24], and investigated the level of dAkt phosphor-
ylation in reference to wild-type tissue. If S6K mediates the
feedback inhibition emanating from TORC1, dAkt phosphoryla-
tion should be increased in s6Kl-1 cells, since the inhibitory
feedback on dAkt would be released. To our surprise, no change in
P-dAkt level was apparent (Figure 6A), suggesting that S6K does
not regulate the negative feedback signaling mediated by Tsc1/
Tsc2 and TORC1 at this stage of wing imaginal disc development.
Because this in vivo finding differed strikingly from the results in
Drosophila cell culture, we verified that the s6Kl-1 chromosome did
not carry additional mutations. The lethality associated with our
s6Kl-1 stock [24] was rescued by expressing a S6KWT cDNA from
an act-Gal4 driver. To further assess if the phosphorylation status
of dAkt varies in the s6K l-1 mutant background in a tissue
dependent fashion, we performed a western blot analysis of
extracts from whole third instar wild-type and s6Kl-1 mutant larvae
(Figure S5). Consistent with our result in wing imaginal disc clones
of s6K l-1, we did not observe an increase of P-dAkt. However, we
detected a downregulation of total Akt protein expression in
extracts from s6Kl-1 mutant larvae when compared to wt, thus
suggesting additional regulatory mechanisms controlling dAkt in
different tissues.
Most studies on feedback regulation of dAkt by S6K are carried
out in the context of either tsc1 or tsc2 mutants or other
experimental settings of putatively high TORC1 activity [18,87].
This led us to probe the dependence of the feedback inhibition on
S6K in a high TORC1 signaling background induced by a tsc2
mutant context. First, we confirmed that, similar to tsc1Q87X
(Figure 4C), P-dAkt is downregulated in cells homozygously
mutant for tsc2192 (Figure 6B). Subsequently, we generated s6kl-1,
tsc2192 double mutant clones and stained the cells with anti P-dAkt
antiserum (Figure 6C). Surprisingly, and in contrast to s6kl-1 single
mutant clones and tsc2192 single mutant clones, tsc2192, s6kl-1
double mutant tissue of the wing imaginal disc displayed elevated
Figure 5. Epistatic relation of TORC1 to Tsc1. (A-C’) Single tangential optical sections of third instar wing imaginal discs stained with DAPI (A-C,
blue), anti P-dAkt (A-C, A’-C’ red) and anti-GFP (A-C, green). (A, A’) View of the dorso-ventral boundary located on the wing primordium. GFP
expression (green) marks the expression domain of apterous-Gal4 driver and the UAS-raptorRNAi hairpin expression construct. (B, B’) tsc1W243X
homozygous mutant clone located at the wing primordium. (C, C’) Homozygous mutant clone of tsc1W243X simultaneously expressing UAS-raptorRNAi
located on the wing primordium. Mutant clones are marked by the expression of GFP (green) in B and C. A’, B’ and C’ show P-dAkt channel only, the
compartment boundary (A’) or the boundaries of the clones (B’, C’) are traced by a white line. Genotypes: (A, A’) yw; ap-Gal4/+, UAS-raptorRNAi/+. (B, B’)
hs-Flp, UAS-CD8::GFP; tub-Gal4/+; FRT82B, tsc1W243X/FRT82B, tub-Gal80. (C,C’) hs-Flp, UAS-CD8::GFP; tub-Gal4/+;UAS-raptorRNAi,FRT82B, tsc1W243X/FRT82B,
tub-Gal80.
doi:10.1371/journal.pgen.1000990.g005
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P-dAkt levels compared to wild-type cells (Figure 6). We observed
a similar result using a different allelic combination, s6Kl-1, tsc2*
(data not shown). This result suggests that the feedback inhibition
of dAkt phosphorylation depends on S6K only when TORC1
signaling is elevated above its wild-type activity.
S6K as sensor and regulator of dAkt–TOR signaling
activity
The observation that ablation of S6K function only affects
feedback inhibition of dAkt phosphorylation when TORC1
signaling is elevated suggests that activation of S6K by TORC1
in a wild-type context is insufficient to affect dAkt phosphorylation.
The activation of S6K by TORC1 involves phosphorylation of
several sites in the auto-inhibitory domain and the linker region of
S6K [88,89]. We used ap-Gal4 to express either wild-type S6K
(S6KWT), or mutant S6K forms (S6KTE, S6KSTDE or S6KSTDETE
[90], which are intrinsically activated due to substitution of several
serine and threonine residues by acidic amino acids in the linker
(S6KTE), the autoinhibitory domain (S6KSTDE), or both
(S6KSTDETE). Overexpression of S6KWT did not visibly change
the level of dAkt phosphorylation when compared to ventral, non-
S6K-expressing control cells (Figure S6). However, expression of
the activated alleles S6KTE, S6KSTDETE and, to a limited extent,
S6KSTDE, resulted in decreased dAkt phosphorylation, when
compared to ventral non-expressing cells, reminiscent of the effect
of high TORC1 signaling. We further addressed whether activated
S6K is also sufficient to elicit inhibition of P-dAkt when TORC1
activity is low. To this end, we co-expressed Tsc1 and Tsc2, to
dominantly inhibit TORC1, and assessed P-dAkt levels in the
absence or presence of S6KTE co-expression (Figure S7). As
observed above (Figure 4), Tsc1/Tsc2 expression caused a
pronounced increase in P-dAkt (Figure S7A and S7A’). Strikingly,
simultaneous expression of dominant active S6K (S6KTE, Figure
S7B and S7B’) reversed the elevated P-dAkt down to a near wild-
type level. Altogether, these results suggest that activation of S6K
is sufficient to elicit feedback inhibition of dAkt phosphorylation
under normal or inhibited TORC1 activity levels. However, in
wild-type wing imaginal disc cells, endogenous S6K is not
sufficiently activated to regulate the feedback inhibition of dAkt
phosphorylation. These results suggest that S6K serves as a sensor
and homeostatic regulator of dAkt-TOR signaling intensity in vivo.
Discussion
Akt signaling provides a critical nexus between PI3K and
TORC1 signaling. Excessive activation of dAkt and its effector
pathways drives unrestricted cell growth and proliferation, as
Figure 6. Negative feedback to Akt is S6K–independent in a wild-type background, and S6K–dependent in a tsc2 mutant
background. (A-C’) Single tangential optical sections of third instar wing imaginal discs stained with DAPI (A-C, blue), anti P-dAkt (A-C, A’-C’,
red) and anti-GFP (A-C, green). All mutant clones shown here are marked by the absence of GFP (green) and are traced by a white line (A’-C’). (A, A’)
s6Kl-1 homozygous mutant clone located at the wing primordium. (B, B’) tsc2192 homozygous mutant clone. (C,C’) Homozygous clone simultaneously
mutant for tsc2192 and s6Kl-1. A’, B’ and C’ show P-dAkt channel (red) only. Genotypes: (A, A’) hs-Flp/+; s6Kl-1, FRT80B/ubi-GFP, FRT80B. (B, B’) hs-Flp;
tsc2192, FRT80B/ubi-GFP, FRT80B. (C,C’) hs-Flp; s6Kl-1, tsc2192, FRT80B/ubi-GFP, FRT80B.
doi:10.1371/journal.pgen.1000990.g006
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observed in cancers. Conversely, an impaired response of Akt to
stimulating factors like insulin in peripheral tissues contributes to
metabolic syndromes and diabetes mellitus. Hence, the activity of
Akt-TOR signaling needs to be maintained within well-defined
physiological boundaries within a critical upper as well as lower
limit. We now provide the first evidence that, during development,
negative feedback monitors and autoregulates the activity of the
dAkt-TOR signaling pathway in wing imaginal disc tissue in vivo.
We studied the control of dAkt activation in Drosophila Kc167
cells and in vivo using the wing disc of the Drosophila third instar
larva. Our results highlight that dAkt centers itself in a circular
pathway with two modes of negative feedback regulation (Figure 7).
Consequently, the levels of dAkt phosphorylation in vivo are
controlled not only by the input by extracellular factors into the
signaling pathway, but also by the amplitude of the dAkt-TORC1
signal itself. In the wild-type context of the third instar wing disc,
the negative feedback on dAkt phosphorylation is mediated by
TORC1 and is S6K-independent. Interestingly, increased dAkt-
TOR signaling activity switches the mechanism of negative
feedback from an S6K-independent- to an S6K-dependent
feedback mode (Figure 6). We interpret this finding as a rewiring
of the dAkt-TOR signaling network that illustrates a dynamic
response of a signaling circuit to signaling loads.
TORC1–dependent feedback control of dAkt
phosphorylation in vivo
Our initial experiments on dAkt phosphorylation in wing
imaginal discs demonstrated that expression of activated PI3K
(PI3KCAAX) or dominant negative InR (InRK1409A) elevated or
repressed, respectively, the level of dAkt phosphorylation. This
observation indicates that in these cells, dAkt phosphorylation
can be enhanced or repressed, depending on the signaling input,
and thus that dAkt has ‘‘room’’ for quantitative regulation of
activation. Accordingly, high levels of negative feedback, caused
by mutational inactivation of tsc1 or tsc2, suppress dAkt
phosphorylation, while low levels of negative feedback signaling,
as in RaptorRNAi-expressing cells, enhance dAkt phosphorylation.
These results lead to the conclusion that the wild-type level of
dAkt phosphorylation in these cells is set by negative feedback
regulation that is executed by the Tsc1/Tsc2-Rheb-TORC1
arm of the dAkt-TOR pathway. Interestingly, in s6Kl-1 mutant
clones, levels of P-dAkt are unchanged, indicating the indepen-
dence of the negative feedback circuit from S6K activity under
these conditions. These results differ from the reported elevated
Akt kinase activity in extracts from whole s6Kl-1 second instar
larvae [65,91]. Studies of whole larval extracts may reflect the
regulation in endoreplicating tissues, which dominate the body
mass at that stage of development, whereas our results of s6Kl-1
mutant clones in the wing disc examine Akt phosphorylation in a
mitotically active tissue. The disparity in Akt phosphorylation
may therefore reflect differences in negative feedback regulation
of Akt at discrete stages of development and in distinct tissues.
The recent observation that inhibition of TORC1 by rapamycin
treatment in adult flies results in loss of S6K phosphorylation
and, presumably, activity without eliciting changes in dAkt
phosphorylation serves as a case in point [92]. The tissue
Figure 7. Model of the Akt–TOR signaling transduction network in vivo. Under wild-type conditions, negative feedback to the PI3K/Akt
signaling branch is mediated by TORC1 (containing TOR, Lst8 and Raptor), independently of S6K. Under conditions of high TORC1 signaling load,
induced e.g. by mutations in tsc1 or tsc2, negative feedback becomes S6K dependent. See discussion for details.
doi:10.1371/journal.pgen.1000990.g007
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specificity of dAkt feedback regulation will be an interesting topic
of future investigation.
In the wing imaginal disc, the feedback-driven changes in dAkt
phosphorylation occur in a manner that is uncoupled from
changes in dAkt protein expression. Indeed, the genetic manip-
ulations that resulted in changes in dAkt-TOR signaling activity
left the dAkt expression levels unchanged. The only exception of a
slight reduction in overall dAkt level, yet increased dAkt
phosphorylation, was observed upon expression of PI3KCAAX
(see Figure S3E and S3E’). We therefore propose that, in the wing
imaginal disc, a change in the phosphorylation status of dAkt, but
not in protein expression, represents the relevant regulatory event
in vivo that is targeted by TORC1-dependent negative feedback.
Changes in dAkt activity by manipulating the negative feedback
can have significant biological effects [42,93,94]. In contrast to our
findings in wing discs, we do observe a reduction of Akt protein
levels in whole third instar larval extracts of s6Kl-1 mutants. Since
in third instar larvae the wing imaginal discs represent only a
minor and select fraction of cells and tissues, the mass disparity of
larval vs. imaginal wing tissue may explain this differing result of
dAkt in our western blot vs. the clonal wing imaginal disc analysis.
Of note, our western blot analyses differed significantly from those
reported by Radimerki et al. [65,91], in the use of third versus
second instar larval extracts, differences in protein extraction,
antibodies, and normalization against total protein versus Akt
levels. We interpret the divergent results as due to different assays
and developmental stages analyzed. Importantly, a change of Akt
protein levels under altered Akt-TOR signaling conditions is not
unprecedented [95].
Although the TORC1-dependent feedback needs to be
biochemically characterized, two mechanisms may be envisioned.
First, TORC1 could participate in an inhibitory step required for
downregulation of dAkt activity. This possibility may be supported
by experimental evidence that TORC1 can elicit a direct
inhibitory phosphorylation of IRS1 in mammalian cell culture
[96,97]. Second, disruption of TORC1 by RNAi knockdown
against specific components of the complex may release the
remaining components of TORC1, and might shift a mass-action
equilibrium between TORC1 and TORC2 towards TORC2.
While such equilibrium has been suggested [98], there is, to our
knowledge, only experimental evidence for an equilibrium shift
towards TORC1 when TORC2 is disrupted, but not vice versa
[16,50]. Lastly, in mammalian cells the Tsc1/Tsc2 complex is
required for proper TORC2 activation, independently from its
role in negative feedback signaling [99]. Nevertheless, we observe
that RaptorRNAi hairpin expression reverses the decrease in dAkt
phosphorylation in a tsc1 mutant clone, although not to the same
extent as expression of the RaptorRNAi hairpin driven by ap-Gal4.
These findings suggest that negative feedback is a central route of
Tsc1/Tsc2 to regulate dAkt phosphorylation. However, we cannot
exclude a functional role of Tsc1/Tsc2 in the activation of
TORC2 [99].
dAkt–TOR pathway feedback in Drosophila cell culture
versus in vivo
We also provide evidence for S6K-dependent negative feedback
inhibiting the phosphorylation of dAkt in vivo. The S6K-dependent
mode of feedback was previously proposed based on data in
mammalian or Drosophila cell culture. Accordingly, we observed an
S6K-dependent negative feedback circuit inhibiting the phosphor-
ylation of dAkt in Drosophila Kc176 cells [65,66,67]. In vivo,
however, this mode of feedback was observed only in cells with
high TORC1 signaling, and was not seen in wild-type conditions,
where the negative feedback mechanism is TORC1-dependent
and does not depend on S6K. We therefore propose that in the
wing imaginal disc, under conditions of high TORC1 signaling,
the cells switch their feedback mechanism from a TORC1-
dependent mode to an S6K-dependent mechanism similar to what
is observed in Kc167 cell culture. We suggest that the constant
presence of serum, insulin and high amino acid concentrations in
the cell culture medium foster high TORC1 activity, favoring the
S6K dependent negative feedback route. However, it is possible
that in cultured Kc167 cells, both feedback mechanisms are
simultaneously operative. Indeed, we found that, in Kc167 cells,
RNAi-mediated knockdown of the TORC1 component Raptor
triggers a stronger increase in dAkt phosphorylation than RNAi
against S6K (see Figure S2B and Figure S8).
dAkt activity and cell size
The elevated dAkt phosphorylation observed in cells with
increased Tsc1 and Tsc2 expression strongly supports a negative
feedback regulation of dAkt phosphorylation by the Tsc1/Tsc2
complex in vivo. Nevertheless, this finding is surprising at two levels.
First, dAkt has been described as a positive regulator of cell size,
and aktq homozygous mutant clones show reduced cell size [100].
However, forced expression of Tsc1/Tsc2 results in reduced cell
size, despite elevated dAkt phosphorylation [76,77,78]. The
reciprocal experiment highlights the same paradox: tsc1Q87X or
tsc2192 mutant cells have a larger size, despite decreased dAkt
phosphorylation and activity [76,77,78]. These results may
indicate that, for cell size, dAkt’s function is to regulate Tsc1/
Tsc2 activity, which is supported by the fact that so far no other
dAkt substrate (e.g. FoxO, Gsk3beta) has been shown to elicit a
cell size defect [81]. Correspondingly, the ability of Akt1 and Akt2
deficiency to suppress H-Ras mediated oncogenesis in mouse
mammary glands is overcome by inactivation of tsc2, again
supporting the hypothesis that a central function of dAkt in vivo is
the regulation of TORC1 activity [101]. The consistency of the
data in Drosophila with those in mice indicates that this function of
dAkt in dAkt-TOR signaling is conserved. The second surprise
relates to the elevated dAkt phosphorylation in the presence of
ectopic Tsc1/Tsc2 expression, which may at first seem intuitive.
The circular structure predicts that increased Tsc1/Tsc2 expres-
sion should inactivate the feedback inhibition of dAkt phosphor-
ylation by repressing TORC1, thus releasing dAkt from negative
feedback regulation, hence increasing dAkt phosphorylation.
However, a perfectly circular dAkt-TOR pathway predicts that
increased Tsc1/Tsc2 levels should trigger high dAkt activity,
which in turn should inactivate the Tsc1/Tsc2 complex by direct
phosphorylation of Tsc2 [75,102,103]. Thus, depending on the
strength of the dAkt-Tsc2 connection, dAkt phosphorylation could
either remain unchanged or even be reduced. However, the dAkt-
Tsc2 link might be less physiologically relevant than initially
suggested [75,104,105], pointing to additional regulatory connec-
tions of the InR-PI3K-dAkt and Tsc1/Tsc2-Rheb-TORC1
signaling branches [20,99,106,107,108,109]. Alternatively, over-
expressed Tsc1/Tsc2 may localize to a subcellular compartment
where it escapes phosphorylation by active dAkt, yet can inhibit
TORC1, or the derepressed activity level of dAkt might be
insufficient to effectively control overexpressed Tsc1/Tsc2.
S6K serves as a sensor of TORC1 signaling load in vivo
In the developing Drosophila wing disc, S6K is a central mediator
of TORC1 activity, especially as the fly 4E-BP1 ortholog, Thor, is
not expressed [110]. Since ectopic expression of activated S6K,
but not wild-type S6K, results in decreased dAkt phosphorylation,
we conclude that S6K activation is sufficient to elicit a negative
feedback on dAkt. In the activated S6K mutants, sites in the linker
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and autoinhibitory domain that are normally phosphorylated by
TORC1 are replaced by phospho-mimetic acidic amino acids
[90]. Our data therefore suggest that linker and the autoinhibitory
domain phosphorylation of S6K may function as sensor for the
TORC1 signaling load. Thus, only when TORC1 is highly active,
S6K will become sufficiently phosphorylated to drive the negative
feedback, a scenario that is mimicked by ectopic expression of
activated S6K. Of note, the S6KTE and S6KSTDETE phospho-
mimetic mutants, which have the linker site mutation, exert a
visibly stronger inhibition of dAkt phosphorylation than the
S6KSDTE phospho-mimetic mutant of the autoinhibitory domain
only. These differences may suggest that the phosphorylation site
in the linker region of S6K is the predominant site for transducing
TORC1 activity. In Drosophila cell culture, supra-physiological
levels of nutrients and amino acids may then trigger the high
TORC1 activity required to drive S6K-mediated feedback on
dAkt phosphorylation.
Since mTOR has recently been shown to be targeted for
phosphorylation by S6K [111], it is tempting to speculate about a
mechanism involving a feedback by S6K on TORC1 that then
could drive the switch between TORC1- and S6K-dependent
feedback inhibition of Akt phosphorylation. However, the T2446
and S2448 sites in mTor that are phosphorylated by S6K are not
conserved in Drosophila TOR.
In conclusion, we demonstrate that dependent on TORC1
signaling load, the negative feedback signal regulating dAkt
activity is dynamically routed in vivo. It is either independent of
S6K (under ‘‘normal’’ TORC1 activity) or dependent on S6K
(when TORC1 activity is high). Therefore, we interpret the
function of S6K as a sensor of TORC1 signaling that selectively
provides additional dampening of the signaling input once
TORC1 is highly active. These findings predict that pharmaco-
logical tools selectively impinging on S6K activity, in the context of
obesity treatment or other conditions with high S6K activity,
might carry the significant risk of uncontrollable TORC1 activity.
Material and Methods
Cell culture and RNAi in Drosophila Kc167 cells
For 384-well plate experiments, cells were uniformly dispensed
into clear bottom black 384-well plates (Corning) containing
250ng of individual, arrayed dsRNAs using a MultiDrop liquid
dispenser (Thermo). 86103 cells per well in 10 ul of serum-free
media per well were seeded. After 60 min of incubation, 70 ul of
10% serum-containing culture medium (Schneider’s Medium,
Invitrogen) per well was added. After three days of incubation at
25uC, cells were washed once and starved in 80 ul serum-free
medium overnight (12 hrs). For insulin stimulation, cells were
exposed to a final concentration of 387 nM bovine insulin (Sigma)
for 10 min. Rapamycin was used at a final concentration of
50 nM for 4 hrs, amino acid free media (Atlanta Biologicals) was
used for 8 hrs. For western blotting, six-well dishes wereused and
the conditions were scaled accordingly. 10 ug of dsRNA per well
was added to 1.56106 cells per well in 1 ml of serum-free media,
supplemented after 60 min with 5 ml of serum-containing media.
For immunofluorescence, we used eight-well chamber slides, and
cells were treated as described above, using 2 ug of dsRNA per
well in 100 ul of serum-free media, complemented with 500 ul of
serum-containing media after 60 min. All primer sequences of the
genome-wide dsRNA library are available on the website of the
Drosophila RNAi Screening Center (www.flyrnai.org). dsRNAs
were generated from PCR-derived DNA templates by T7 RNA
polymerase driven run-off transcription in vitro (Ambion). The
generic T7 promoter sequence TAATACGACTCACTATAGG
was added 59 to all gene specific primers. All gene-specific primers
were designed using Primer3 [112], and conceptual PCR products
were controlled against off-target effects using SnapDragon
(http://flyrnai.org/cgi-bin/RNAi_find_primers.pl). Gene-specific
primer sequences used: GFP: CAAGGGCGAGGAGCTGTT,
GTCGTCCTTGAAGAAGATGGTG; CSK: GAGGAAGCA-
GACGGCAAC, GGGACTTGGGCGAATGAT;MEKK1: AAG-
TGTGTGTTGGTGCTGGA, ATCTTCGGGAGGCAGGTC;
Thread: GCTGGACTGGCTGGATAAAC, ATTCGGGATAC-
TGGGGAAAA; InR: CAGCGCGAAAACTTCAATATCTTT,
TGTTTTATCCAGTCCATCGGCTAT; Chico: CCAAGCATA-
GATTTGTCATTGTGC, GATCACCAGATCCCAAGACAC-
TTT; PI3K92E: GAGGCACCAGATCCAAAATC, ATACAG-
CCGGAAGTCGTCAA; PI3K21B: GCTTTATCGAGACGGA-
CCTG, GCATCCAGCAGATTGAGGAG; Pten: TGTATTAT-
GCCAAGCGGAAGA, TCAATCGTTGGAGGGTTATGA, dAkt:
GTCCACAAATCATCCGTTCC, ACCTCCTCCACCAAAA-
TCAA; Tsc1: GAGGTAAACAATACGCGATGGAAG, AACT-
GAACTGACTCTGCTGGTCCT; Tsc2: CTAGACAGTCGT-
CAGGTGATCGTG, ACGCGACTAAGGATTTCTTCTTCA;
S6K: TCTGCACCAAGACACTGAGG, GCAGTATGTTCT-
CGGGCTTC; Raptor: ACCTGGGTAAGGTGATTAGCAACA,
AGGTGCAGAGCTTCTTAACGTCAT; Rheb: GCTAGGAG-
TGGTATTTCGGCTTC, CCAGTGCTTTGAAATAAATGG-
AGA; PDK1: CAAGGAGAAAGCATCAGCAA, GCCTATG-
TAACGACCGAAAATG.
Protein extracts and western bloting
Kc167 cells were rinsed once, scraped in PBS, and pelleted at
low speed in a table top centrifuge. The cell pellet was lysed in
standard SDS-PAGE loading buffer without dye. Extracts of third
instar larvae were prepared by mechanical homogenization and
lysis in 50 mM Tris, 120 mM NaCl, 30 mM NaF, 50 uM
NaVO4, 1% Triton X100, 0.1% SDS with Complete protease
inhibitor cocktail (Roche). Lysates were cleared from debris and
lipids by 10 min centrifugation in a table top centrifuge. For all
protein lysates, protein concentrations were determined using
Protein DC Assay (Bio-Rad), and total protein concentrations of
lysates were adjusted accordingly.
Cytoblot
The Cytoblot protocol for 384 well plates used here consists of 4
steps: (1) fixation, (2) permeabilization, (3) P-dAkt staining
comprising of incubations with primary and secondary antibodies,
and (4) DNA staining to assess total cell numbers in each
individual well. Two versions of the cytoblot were used. The ‘‘first
generation’’ cytoblot utilized HRP-conjugated secondary antibody
and chemiluminescence to detect anti P-dAkt. This protocol was
applied to the non-stimulated RNAi screen. The ‘‘second
generation’’ cytoblot employed a fluorescently labeled secondary
antibody and was used for the insulin-stimulated RNAi screen.
The availability of a LiCor Aerius plate reader allowed the switch
from luminescence to fluorescence based detection.
(1) Fixation: Tissue culture medium from the 384 well plates was
removed and cells were fixed with 6% Formaldehyde for 90
minutes, followed by three washes with 80 ul of PBS. (2)
Permeabilization: 0.1% Triton X-100 in PBS for 30 minutes
(40 ul per well), followed by 3 washes in 80 ul PBS for 10 min. (3)
P-dAkt staining: Cells were blocked in 5% non-fat milk in PBS for
60 minutes (90 ul per well). Anti-Drosophila P-dAkt Ser505 primary
antibody (20 ul per well, 1:800 diluted in 5% non-fat milk, Cell
Signaling Technology, Beverley, MA) was added and incubated at
4uC overnight. After 3 washes with PBS (80 ul per well, 10 min),
20 ul secondary antibody (goat anti-Rabbit AlexaFluor 680,
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diluted 1:2,500, Invitrogen, for ‘‘second generation Cytoblot’’,
used for insulin-stimulated RNAi screens) or a 1:1,200 dilution of
goat anti-Rabbit HRP (‘‘first generation Cytoblot’’, used for
insulin-stimulated RNAi screen, Jackson Laboratories), was added
in 5% non-fat milk and incubated for 4 hrs, followed by 3 washes
with 80 ul of PBS, 10 min and 20 ul PBS was added to each well.
Signal was developed by 20 ul SuperSignal West Pico Chemilu-
minescent Substrate (Pierce). HRP luminescence was read in
Molecular Devices plate reader. Alexa 680 fluorescence was
measured using a LiCor Aerius plate reader (680/720 nm). HRP
luminescence and Alexa 680 fluorescence were interpreted as
amounts of P-dAkt per well. (4) DNA staining was performed with
Sytox Green (Invitrogen) 1:20,000 in PBS for 30 min (40 ul per
well). After 3 additional washes with PBS, plates were filled with
20 ul PBS per well and the fluorescent value of the Sytox dye
DNA stain were read in a Molecular Devices plate reader (520/
560 nm). This value, referred hereafter to as nuclear fluorescence
(NucFl), is interpreted as the value representing relative cell
numbers per well. All liquid manipulation steps were performed
using a MultiDrop liquid handling device (Thermo).
Data analysis
All individual values quantifying amounts of P-dAkt were
normalized to the cell number per well using the nuclear fluorescent
value from the DNA stain. For the insulin-stimulated screen, linear
regression was performed on the log2(P-dAkt/NucFl) values of each
individual screen plate, and residuals from the log2(P-dAkt/NucFl)
values to the regression line were calculated. All residuals of each
genome-wide screen were pooled and a cell number dependent error
model was developed to determine locally weighted standard
deviations (SD) and averages in dependence of cell number. Z-
Scores using these two parameters were calculated, expressing the
deviation from the local average value in SDs. All Z-Scores were
corrected against position effects by setting the Mean Z-Score of each
individual well position across one genome-wide screen replicate to
zero. All dsRNAs with predicted off-target effects (homologies to non-
target genes of 19 bp or more) were excluded from data processing
and the result file. Results from the two screening replicates were
averaged and a cut-off value of +/2 2.5 applied. Due to high
variation within each 384 well screening plate caused by individual
96-well source plates (each 384-well screening plate is composed of
aliquots from four 96-well source plates), Z-Scores for the baseline (no
insulin stimulation) genome wide RNAi screen were calculated as
follows: The 384 (P-dAkt/NucFl) values of each single screening plate
were decomposed into the four 96 well groups, each defined by a
single source plate, and the mean and SD was set to zero and one,
respectively. This step compensated these inequalities, and data were
recombined to 384 well plate data sets. Mean and SD for each
individual 384 well plate were calculated, averaged between screens,
and a cut-off value of three SDs was applied. For non-genome-wide
RNAi experiments, an external standard consisting of 768 values of
non-RNAi treated cells covering the whole spectrum of cell densities
was used to determine cell number dependent averages and SDs to
calculate experimental Z-Scores of RNAi treated wells. All P-dAkt
values of non-stimulated cells were normalized using a baseline
standard curve (the average non-treated, non-stimulated experiment
scores zero). For the insulin-stimulated data set, the P-dAkt values of
insulin-treated cells were normalized using a standard curve derived
from insulin-stimulated cells (the average non-treated, insulin-
stimulated experiment scores zero).
Antibodies
All P-dAkt indirect immunofluorescence images, Cytoblots and
western blots were performed using anti-Drosophila P-dAkt Ser505
(Lot 1 and Lot 2, Cell Signaling Technology) using a 1:200, 1:800
and 1:200 dilution, respectively. For immunofluorescence, Alexa-
Fluor594 and AlexaFluor488 conjugated secondary antibodies
against Rabbit, Mouse and Goat were used 1:500 (Invitrogen).
Western blotting was performed using HRP conjugated anti-rabbit
and anti-mouse antisera (Amersham). Pan-dAkt and P-S6K
Ser398 (Cell Signaling Technology) were used 1:200. Anti-GFP
was purchased from Cappel and used at 1:4000. Mouse anti
alpha-Tubulin (Sigma) was used 1:2000 for immunofluorescence.
Rabbit anti S6K was a generous gift from Mary Steward and used
1:10,000 for western blotting.
Immunofluorescence, confocal microscopy, and image
processing
Imaginal discs and Drosophila Kc167 cells were fixed using 6%
Formaldyhyde in PBS (cells 10 min at room temperature, imaginal
discs at 4uC overnight), permeabilized in 0.1% Triton X-100
(10 min for cells, 2 hrs for imaginal discs) and blocked with 5%
BSA in PBS (1 hr). Primary antibody incubation was performed
overnight at 4uC with antibody dilutions as indicated above, using
5% BSA. After 3 washes with PBS, secondary antibody was
incubated overnight in 5% BSA, followed by 3 washes in PBS.
Specimens were mounted using Vectrashield mounting medium
with DAPI (Vector Co.). All data were acquired using a Leica SP2
confocal microscope, a 63x lens, digital zoom factor of four,
102461024 pixel detector setting and processed using Adobe
Photoshop software. Images of experimental and control cells were
processed identically.
Genetics
Mutant wing imaginal disc clones were generated by FLP/
FRT-mediated mitotic recombination using the following chro-
mosomes: FRT82B, aktq [72]; FRT82B, aktq, tsc1Q87X [76];
FRT82B, aktEX4 (derived by imprecise excision from aktP04226,
Bloomington Stock center) FRT82, tsc1Q87X [77]; FRT82B,
tsc1W243X [77]; FRT82B, foxo25 [81]; FRT82B, foxo25, aktq [81];
tsc2192, FRT80B [77]; tsc2*, FRT80B (generous gift from I.K.
Hariharan); s6Kl-1, FRT80B [24]; s6Kl-1, tsc2192, FRT80B [71];
s6Kl-1, tsc2*, FRT80B. Males of the respective genotypes were
crossed to y,w,hs-FLP,UAS-mCD8::GFP; tub-Gal4; FRT82B,tub-
Gal80/TM6B or y,w,hs-FLP, ubi-GFP, FRT80B females and larvae
were heat shocked 60 hrs +/2 12 hrs after egg laying (unless
otherwise specified) at 37uC for 45 min. Overexpression of
PI3KCAAX [113], InRDN (Bloomington Drosophila Stock Center),
Tsc1 and Tsc2 [77], FoxoTM [80], S6KWT [78], S6KTE, S6KSTDE
and S6KSTDETE [90] in the dorsal compartment of the wing
imaginal disc was performed using the Gal4-UAS system [58] with
y,w; ap-Gal4,UAS-mCD8::GFP (gift from C. Micchelli). The
RaptorRNAi hairpin and transgenic line was generated using the
VALIUM1 vector [114] as part of the transgenic RNAi project
(TRIP, http://flyrnai.org/TRiP-HOME.html).
Gene names
Based on BLAST searches, information in the public ortholog
databases InParanoid [115], and Homologene [116] published
sequence homologies [117], CG3004 (Fbgn0030142), and
CG10105 (Fbgn0033935) were referred to as Lst8 and Sin1
[29,50], respectively.
Supporting Information
Figure S1 Western blot of total extracts prepared from Drosophila
Kc167 cells at base line (lanes 1-6) or insulin stimulation (lanes 7-12)
treated with dsRNAs as indicated and blotted with anti Pan-dAkt,
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anti P-dAkt, and anti-Tubulin as loading control. Top and bottom
panels of anti alpha-Tubulin western blots are loading controls for
the anti P-dAkt and anti Pan-dAkt western blots, respectively.
Note that lane 10 from the right, (insulin-stimulated, dPDK1
RNAi treated cells) is underloaded.
Found at: doi:10.1371/journal.pgen.1000990.s001 (1.35 MB TIF)
Figure S2 Genome wide screen for regulators of dAkt (Ser505)
phosphorylation. (A) Cartoon of the cytoblot technique used to
screen 586384 well plates containing dsRNAs covering the entire
Drosophila genome. Each screen was performed in duplicates.
Experimental values for dAkt phosphorylation are normalized to
the individual cell numbers per well determined by a DNA dye
staining. See experimental procedures for details. (B, C) Ranked Z-
Scores (corresponding to relative P-dAkt levels) of genome wide
RNAi screens at baseline (B) and Insulin stimulation (C) with the
known components of InR and Tor signaling marked in red.
Found at: doi:10.1371/journal.pgen.1000990.s002 (0.45 MB TIF)
Figure S3 Analysis of in vivo dAkt protein expression in various
genetic gain- and loss-of-function backgrounds of the dAkt–TOR
signaling pathway. Single tangential optical sections of third instar
wing imaginal discs stained with DAPI (A-C, blue), anti Pan-dAkt
(A-H, A’-H’ red) and anti-GFP (A-H, green). Mitotic clones shown
in (A,A’, B,B’ and G,G’) are marked by the expression of GFP
(green). Clones shown in (C,C’ and D,D) are marked by the
absence of GFP (green). All other images depict apterous-Gal4
derived co-expression of various constructs with CD8::GFP. (A,A’)
Specificity control of anti Pan-dAkt. Clone of homozygously aktEX4
mutant cells (aktEX4 is a derivative of aktP04226, generated by
imprecise excision). Note the cell autonomous loss of the Pan-dAkt
antigen. (B,B’) aktq clone. (C,C’) tsc2192 clone. (D,D’) s6Kl-1, tsc2192
clone. (E,E’) Expression of an activated catalytic subunit of PI3
Kinase (PI3K92ECAAX). Note the lower expression of dAkt in the
PI3KCAAX expressing compartment, accompanied by high P-dAkt
levels (Figure 1). (F,F’) Ectopic expression of RaptorRNAi. (G,G’)
Clone of tsc1W243X simultaneously expressing RaptorRNAi. (H,H’)
Ectopic expression of S6KSTDE. Genotypes: (A,A’): hs-FLP, UAS-
GFPnuc, tub-Gal4; FRT82B, aktEX4/FTR82B, tub-Gal80, M. (B,B’):
hs-FLP, UAS-GFPnuc, tub-Gal4; FRT82B, aktq/FTR82B, tub-Gal80,
M. (C,C’): hs-Flp; tsc2192, FRT80B/ubi-GFP, FRT80B. (D,D’): hs-
Flp; s6Kl-1, tsc2192, FRT80B/ubi-GFP, FRT80B. (E,E’): yw/UAS-
PI3K92ECAAX; ap-Gal4/+. (F,F’): yw; ap-Gal4/+, UAS-raptorRNAi.
(G,G’): hs-Flp, UAS-CD8::GFP; tub-Gal4/+;UAS-raptorRNAi,FRT82B,
tsc1W243X/FRT82B, tub-Gal80. (H,H’): yw; ap-Gal4/+,UAS-
S6KSTDE.
Found at: doi:10.1371/journal.pgen.1000990.s003 (5.87 MB TIF)
Figure S4 Negative feedback regulation of the dAkt-TOR
pathway is independent of dFOXO. (A-C’) Single tangential
optical sections of third instar wing imaginal discs stained with
DAPI (A-C, blue), anti P-dAkt (A-C, A’-C’, red) and anti-GFP (A-
C, green). (A, A’): Magnified view on the dorso-ventral boundary
at the wing primordium. GFP expression (green) marks the dorsal
expression domain of apterous-Gal4 driver and the activated UAS-
dFOXOTM expression construct [80]. (B, B’): homozygous foxo25
loss of function MARCM clone. Homozygous cells for foxo25 are
marked by CD8::GFP coexpression (green). (C,C’): foxo25, aktq
homozygous loss of function MARCM clone. Homozygous cells
for foxo25, aktq are marked by CD8::GFP (green). D/V compart-
ment boundary as well as borders of the clones are traced by a
white line in (A’-C’). Genotypes: (A, A’) yw; ap-Gal4/+, UAS-
FOXO-TM/+. (B, B’) hs-Flp, UAS-CD8::GFP/+; tub-Gal4/+;
FRT82B, foxo25/FRT82B, tub-Gal80. (C,C’) hs-Flp, UAS-
CD8::GFP/+; tub-Gal4/+; FRT82B, foxo25, aktq/FRT82B, tub-Gal80.
Found at: doi:10.1371/journal.pgen.1000990.s004 (6.00 MB TIF)
Figure S5 P-dAkt levels are not elevated in s6Kl-1 whole larval
extracts. Western blot of total lysates prepared from whole third
instar larvae of wt (left lane) and s6Kl-1 (right lane) genetic
backgrounds. Western blots probed with anti Pan-dAkt (total Akt),
anti P-dAkt, anti Pan-S6K (total S6K), anti P-S6K and anti alpha-
Tubulin as loading control.
Found at: doi:10.1371/journal.pgen.1000990.s005 (0.42 MB TIF)
Figure S6 Activated S6K is sufficient to drive negative
regulation of P-dAkt. (A-D’) Single tangential optical sections of
3rd instar wing imaginal discs expressing wild-type and activated
alleles of S6K expressed by apterous-Gal4. Stainings with DAPI (A-
D, blue), anti P-dAkt (A-D, A’-D’, red) and anti-GFP (A-D, green)
are shown. GFP expression (green) marks the expression domain
of the apterous-Gal4 driver and the various UAS-S6K expression
constructs. A’-D’ show P-dAkt channel only, the boundary of
apterous-Gal4 expressing vs. non-expressing cells are marked with
by a white line. Genotypes: (A,A’) yw; ap-Gal4/+, UAS-S6KWT, (B,
B’) yw; ap-Gal4/+, UAS-S6KTE (substitution Thr398Glu in the
linker region). (C, C’) yw; ap-Gal4/+, UAS-S6KSTDETE (combined
substitutions Thr398Glu in the linker region and Ser418Asp and
Thr422Glu in the autoinhibitory domain). (D,D’) yw; ap-Gal4/+,
UAS-S6KSTDE (substitutions Ser418Asp and Thr422Glu in the
autoinhibitory domain).
Found at: doi:10.1371/journal.pgen.1000990.s006 (4.83 MB TIF)
Figure S7 Dominant active S6K is sufficient to inhibit P-dAkt
under low TORC1 activity. (A-B’) Single tangential optical
sections of 3rd instar wing imaginal discs co-expressing Tsc1,
Tsc2 and CD8::GFP (A, A’); and Tsc1, Tsc2, CD8::GFP and a
constitutively activated allele of S6K (S6KTE) (B, B’). Expression of
the transgenes is driven by apterous-Gal4. Staining with DAPI (A-B,
blue), anti P-dAkt (A-B’, red) and anti-GFP (A, B, green) are
shown. GFP expression (green) marks the expression domain of
the apterous-Gal4 driver and the of the various expression constructs
used. A’ and B’ show the P-dAkt channel only, the boundary of
apterous-Gal4 expressing vs. non-expressing cells are marked with
by a white line. Genotypes: (A, A’) yw; UAS-CD8::GFP, ap-Gal4/+;
UAS-Tsc1, UAS-Tsc2/+. (B, B’) yw; UAS-CD8::GFP, ap-Gal4/UAS-
S6KTE; UAS-Tsc1, UAS-Tsc2/+.
Found at: doi:10.1371/journal.pgen.1000990.s007 (4.16 MB TIF)
Figure S8 Raptor and S6K dependent negative feedback on P-
dAkt. (A) Single confocal section of S6K, (B) Raptor, (C) Luciferase
and (D) Pten RNAi treated Drosophila Kc167 cells stained with DAPI
(blue) anti P-dAkt (green) after 10 minutes of insulin stimulation.
Images were recorded and processed using identical conditions.
Note the highest level of anti P-dAkt signal in the Raptor dsRNA
treated cells.
Found at: doi:10.1371/journal.pgen.1000990.s008 (2.64 MB TIF)
Table S1 Amplicons identified in the RNAi screens that
enhance or suppress P-dAkt levels. Averaged Z-Scores from the
two screen replicates of the baseline (no stimulation) and insulin-
stimulated screens are shown. The DRSC amplicon identifies
individual dsRNAs from the genome wide dsRNA set. Primer and
sequence information available at www.flyRNAi.org. With the
exception of the InR pathway components, the hits indicated in
this Table were identified using a single dsRNA and therefore
need further validation to eliminate false positives. Fbgn: Fly base
gene number.
Found at: doi:10.1371/journal.pgen.1000990.s009 (0.03 MB PDF)
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